Spots Global Cancer Trial Database for anaplastic (malignant) meningioma
Every month we try and update this database with for anaplastic (malignant) meningioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma | NCT02847559 | Anaplastic (Mal... Atypical Mening... Grade II Mening... Grade III Menin... Recurrent Menin... Supratentorial ... | Bevacizumab Electric Field ... NovoTTF-200A De... Quality-of-Life... | 18 Years - | Northwestern University |